Should gatifloxacin be included in the model list of essential medicines?

We read with great interest the paper by Falzon et al. [1], which reported that gatifloxacin and moxifloxacin have been recommended by the World Health Organization (WHO) for both longer and shortened regimens in the treatment of rifampicin-resistant (RR) and multidrug-resistant (MDR) tuberculosis (...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The European respiratory journal 2018-02, Vol.51 (2), p.1702329-1702329
Hauptverfasser:	Chiang, Chen-Yuan, Trébucq, Arnaud, Piubello, Alberto, Rieder, Hans L, Van Deun, Armand
Format:	Artikel
Sprache:	eng
Schlagworte:	Fluoroquinolones Gatifloxacin Moxifloxacin Multidrug resistance Rifampin Tuberculosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!